Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Appointed COO
|
|
KERYX BIOPHARMACEUTICALS INC (KERX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 shares
@ $0
Disposed/sold 140,000 options
@ $0 |
|
| 12/13/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,000 shares
@ $0
Disposed/sold 80,000 options
@ $0 |
|
| 12/13/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 162,956 shares
@ $0
Disposed/sold 902,500 options
@ $0 |
|
| 12/13/2018 |
4
| Morrison Jodie Pope (Interim CEO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 120,000 shares
@ $0
Disposed/sold 110,000 options
@ $0 |
|
| 12/13/2018 |
4
| Regan Daniel Paul (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 60,000 shares
@ $0
Disposed/sold 200,000 options
@ $0 |
|
| 12/13/2018 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 20,000 shares
@ $0
Disposed/sold 110,000 options
@ $0 |
|
| 12/13/2018 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 27,333 shares
@ $0
Disposed/sold 140,000 options
@ $0 |
|
| 12/13/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 148,279 shares
@ $0
Disposed/sold 772,500 options
@ $0 |
|
| 12/13/2018 |
4
| Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 186,666 shares
@ $0
Disposed/sold 290,000 options
@ $0 |
|
| 12/13/2018 |
4
| Carberry Christine A. (COO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 10,469 shares
@ $3.22, valued at
$33.7k
Disposed/sold 100,646 shares
@ $0
Disposed/sold 422,500 options
@ $0 |
|
| 12/13/2018 |
4
| BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 35,582,335 shares
@ $4.63, valued at
$164.7M
Granted 4,000,000 shares
@ $0
Disposed/sold 65,374,013 shares
@ $0
Exercised options to buy
@ $4.63, valued at
$0 |
|
| 11/16/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,156 shares
@ $2.77, valued at
$3.2k
|
|
| 11/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,155 shares
@ $2.77, valued at
$3.2k
|
|
| 10/30/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,253 shares
@ $3.07, valued at
$3.8k
|
|
| 10/30/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,254 shares
@ $3.07, valued at
$3.8k
|
|
| 10/22/2018 |
4
| Carberry Christine A. (COO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,040 shares
@ $3.29, valued at
$6.7k
|
|
| 08/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,185 shares
@ $3.04, valued at
$3.6k
|
|
| 08/16/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,186 shares
@ $3.04, valued at
$3.6k
|
|
| 07/31/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,282 shares
@ $3.86, valued at
$4.9k
|
|
| 07/31/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,354 shares
@ $3.86, valued at
$9.1k
|
|
| 07/19/2018 |
4
| Carberry Christine A. (COO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,021 shares
@ $4.49, valued at
$9.1k
|
|
| 07/12/2018 |
4
| Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| Morrison Jodie Pope (Interim CEO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| Regan Daniel Paul (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 07/12/2018 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2018 |
4
| Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Exercised 10,000 options to buy
@ $0.48, valued at
$4.8k
|
|
| 06/12/2018 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,334 shares
@ $5.12, valued at
$6.8k
|
|
| 05/31/2018 |
4
| Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,667 shares
@ $5.22, valued at
$8.7k
|
|
| 05/31/2018 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,333 shares
@ $5.22, valued at
$7k
|
|
| 05/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,158 shares
@ $5.69, valued at
$6.6k
|
|
|
|
|